{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreihljhfgomvc42ngw7llst36dafawbcy6k5sqpbyjbyvw7i52bv2sq",
    "uri": "at://did:plc:rydrhbnljcuqi4sx2vri2jyx/app.bsky.feed.post/3mjx3i4rr4pj2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreiapdl7yeuxxmydlapeo7244ffq3se6gcfrmvezsqfqqqw7fifdboi"
    },
    "mimeType": "image/png",
    "size": 289204
  },
  "path": "/comments/14042920?utm_source=feed&utm_medium=comments&utm_campaign=fark",
  "publishedAt": "2026-04-20T17:45:32.000Z",
  "site": "https://www.fark.com",
  "tags": [
    "[link]",
    "[7 comments]"
  ],
  "textContent": "|  [link] [7 comments]\n---|---",
  "title": "Texas will launch its own clinical trials into ibogaine psychedelic. Luckily, subby spent the last few years building up an immunity to ibogaine powder [Followup]"
}